{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T23:51:33Z","timestamp":1781826693883,"version":"3.54.5"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,28]],"date-time":"2025-03-28T00:00:00Z","timestamp":1743120000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82304634"],"award-info":[{"award-number":["82304634"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003819","name":"Natural Science Foundation of Hubei Province","doi-asserted-by":"publisher","award":["2023AFD022"],"award-info":[{"award-number":["2023AFD022"]}],"id":[{"id":"10.13039\/501100003819","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/j.biopha.2025.118029","type":"journal-article","created":{"date-parts":[[2025,4,3]],"date-time":"2025-04-03T07:35:32Z","timestamp":1743665732000},"page":"118029","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Preparation and comprehensive preclinical study of Peramivir inhalation solution: Achieving accurate drug delivery"],"prefix":"10.1016","volume":"186","author":[{"given":"Chao","family":"Mei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyi","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pian","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingli","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenting","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peipei","family":"Pi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianfang","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenlong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2025.118029_bib1","doi-asserted-by":"crossref","DOI":"10.7326\/AITC202111160","article-title":"Influenza","volume":"174","author":"Uyeki","year":"2021","journal-title":"Ann. Intern Med"},{"key":"10.1016\/j.biopha.2025.118029_bib2","doi-asserted-by":"crossref","DOI":"10.1080\/21505594.2023.2223057","article-title":"Pathogenicity and virulence of influenza","volume":"14","author":"Liang","year":"2023","journal-title":"Virulence"},{"key":"10.1016\/j.biopha.2025.118029_bib3","doi-asserted-by":"crossref","DOI":"10.1128\/cmr.00040-22","article-title":"Antiviral Approaches against Influenza Virus","volume":"36","author":"Kumari","year":"2023","journal-title":"Clin. Microbiol Rev."},{"key":"10.1016\/j.biopha.2025.118029_bib4","doi-asserted-by":"crossref","DOI":"10.3390\/v12010089","article-title":"Epidemiology and Clinical Characteristics of Influenza C Virus","volume":"12","author":"Sederdahl","year":"2020","journal-title":"Viruses"},{"key":"10.1016\/j.biopha.2025.118029_bib5","first-page":"231","article-title":"[The Victoria and Yamagata Lineages of Influenza B Viruses, unknown and undervalued]","volume":"35","author":"Reina","year":"2022","journal-title":"Rev. Esp. Quim."},{"key":"10.1016\/j.biopha.2025.118029_bib6","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/j.arcmed.2009.10.001","article-title":"Comparison of the pathology caused by H1N1, H5N1, and H3N2 influenza viruses","volume":"40","author":"Guarner","year":"2009","journal-title":"Arch. Med Res"},{"key":"10.1016\/j.biopha.2025.118029_bib7","doi-asserted-by":"crossref","first-page":"183","DOI":"10.3390\/cimb46010014","article-title":"Natural History of Influenza B Virus-Current Knowledge on Treatment, Resistance and Therapeutic Options","volume":"46","author":"Din","year":"2023","journal-title":"Curr. Issues Mol. Biol."},{"key":"10.1016\/j.biopha.2025.118029_bib8","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/s11262-022-01904-w","article-title":"An overview of influenza A virus genes, protein functions, and replication cycle highlighting important updates","volume":"58","author":"Chauhan","year":"2022","journal-title":"Virus Genes"},{"key":"10.1016\/j.biopha.2025.118029_bib9","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1007\/s40265-018-0981-8","article-title":"Peramivir: A Review in Uncomplicated Influenza","volume":"78","author":"Scott","year":"2018","journal-title":"Drugs"},{"key":"10.1016\/j.biopha.2025.118029_bib10","doi-asserted-by":"crossref","first-page":"450","DOI":"10.3389\/fmicb.2016.00450","article-title":"Peramivir: A Novel Intravenous Neuraminidase Inhibitor for Treatment of Acute Influenza Infections","volume":"7","author":"Alame","year":"2016","journal-title":"Front Microbiol"},{"key":"10.1016\/j.biopha.2025.118029_bib11","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.2147\/DDDT.S46654","article-title":"Safety and efficacy of Peramivir for influenza treatment","volume":"8","author":"Hata","year":"2014","journal-title":"Drug Des. Devel Ther."},{"key":"10.1016\/j.biopha.2025.118029_bib12","unstructured":"Peramivir. LiverTox: Clinical and Research Information on Drug-Induced Liver Injury. Bethesda (MD)2012."},{"issue":"1","key":"10.1016\/j.biopha.2025.118029_bib13","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1111\/irv.12046","article-title":"Clinical use of approved influenza antivirals: therapy and prophylaxis","volume":"7","author":"Ison","year":"2013","journal-title":"Influenza Other Respir. Virus"},{"key":"10.1016\/j.biopha.2025.118029_bib14","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.antiviral.2016.06.001","article-title":"Global update on the susceptibility of human influenza viruses to neuraminidase inhibitors, 2014-2015","volume":"132","author":"Hurt","year":"2016","journal-title":"Antivir. Res"},{"key":"10.1016\/j.biopha.2025.118029_bib15","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1080\/14656566.2024.2370895","article-title":"Treating influenza with neuraminidase inhibitors: an update of the literature","volume":"25","author":"Bassetti","year":"2024","journal-title":"Expert Opin. Pharm."},{"key":"10.1016\/j.biopha.2025.118029_bib16","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1007\/s10156-011-0288-0","article-title":"Widespread use of neuraminidase inhibitors in Japan","volume":"17","author":"Sugaya","year":"2011","journal-title":"J. Infect. Chemother."},{"key":"10.1016\/j.biopha.2025.118029_bib17","doi-asserted-by":"crossref","first-page":"201","DOI":"10.2147\/IDR.S86460","article-title":"Peramivir injection in the treatment of acute influenza: a review of the literature","volume":"9","author":"Wester","year":"2016","journal-title":"Infect. Drug Resist"},{"key":"10.1016\/j.biopha.2025.118029_bib18","doi-asserted-by":"crossref","DOI":"10.1128\/mbio.01273-23","article-title":"The current state of research on influenza antiviral drug development: drugs in clinical trial and licensed drugs","volume":"14","author":"Li","year":"2023","journal-title":"mBio"},{"key":"10.1016\/j.biopha.2025.118029_bib19","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a038455","article-title":"Antivirals targeting the neuraminidase","volume":"12","author":"Gubareva","year":"2022","journal-title":"Cold Spring Harb. Perspect. Med"},{"key":"10.1016\/j.biopha.2025.118029_bib20","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1146\/annurev-immunol-101921-040450","article-title":"Host recovery from respiratory viral infection","volume":"41","author":"Wei","year":"2023","journal-title":"Annu Rev. Immunol."},{"key":"10.1016\/j.biopha.2025.118029_bib21","doi-asserted-by":"crossref","DOI":"10.3390\/v13102090","article-title":"Innate immune responses to influenza virus infections in the upper respiratory tract","volume":"13","author":"Mifsud","year":"2021","journal-title":"Viruses"},{"key":"10.1016\/j.biopha.2025.118029_bib22","doi-asserted-by":"crossref","first-page":"2803","DOI":"10.1128\/AAC.01718-10","article-title":"Intravenous peramivir for treatment of influenza A and B virus infection in high-risk patients","volume":"55","author":"Kohno","year":"2011","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.biopha.2025.118029_bib23","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1038\/s41579-021-00542-7","article-title":"Influenza virus and SARS-CoV-2: pathogenesis and host responses in the respiratory tract","volume":"19","author":"Flerlage","year":"2021","journal-title":"Nat. Rev. Microbiol"},{"key":"10.1016\/j.biopha.2025.118029_bib24","doi-asserted-by":"crossref","first-page":"4638","DOI":"10.1002\/jmv.26990","article-title":"A brief review of influenza virus infection","volume":"93","author":"Javanian","year":"2021","journal-title":"J. Med Virol."},{"key":"10.1016\/j.biopha.2025.118029_bib25","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1002\/JLB.4RU0820-232R","article-title":"From virus to inflammation, how influenza promotes lung damage","volume":"110","author":"Klomp","year":"2021","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.biopha.2025.118029_bib26","doi-asserted-by":"crossref","DOI":"10.3390\/ijerph19053018","article-title":"Antiviral drugs in influenza","volume":"19","author":"Swierczynska","year":"2022","journal-title":"Int J. Environ. Res Public Health"},{"key":"10.1016\/j.biopha.2025.118029_bib27","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1055\/s-0041-1735491","article-title":"Management of severe influenza","volume":"42","author":"O'Driscoll","year":"2021","journal-title":"Semin Respir. Crit. Care Med"},{"key":"10.1016\/j.biopha.2025.118029_bib28","doi-asserted-by":"crossref","DOI":"10.3390\/ijms231911433","article-title":"Antiviral peptides as anti-influenza agents","volume":"23","author":"Agamennone","year":"2022","journal-title":"Int J. Mol. Sci."}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332225002239?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332225002239?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T23:01:46Z","timestamp":1781823706000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332225002239"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":28,"alternative-id":["S0753332225002239"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2025.118029","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Preparation and comprehensive preclinical study of Peramivir inhalation solution: Achieving accurate drug delivery","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2025.118029","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"118029"}}